Netanel A Horowitz (Netanel Horowitz)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Newly Diagnosed

Respiratory Syndrome Coronavirus

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

American journal of hematology

Cancer medicine

European journal of haematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Ana Belkin, Ofir Deri, Yonatan Oster, Shadi Zahran, Ehud Horwitz, Netanel A Horowitz, Hazim Khatib, Marjorie Vieira Batista, Anita Cassoli Cortez, Tal Brosh-Nissimov, Yafit Segman, Linor Ishay, Regev Cohen, Alaa Atamna, Amy Spallone, Roy F Chemaly, Juan Carlos Ramos-Ramos, Michal Chowers, Evgeny Rogozin, Noga Carmi Oren, Şiran Keske, Orit Wolfovitz Barchad, Lior Nesher, null null
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab. Cancer medicine 13 (3) (2024)
Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Ana Belkin, Ofir Deri, Yonatan Oster, Shadi Zahran, Ehud Horwitz, Netanel A Horowitz, Hazim Khatib, Marjorie Vieira Batista, Anita Cassoli Cortez, Tal Brosh-Nissimov, Yafit Segman, Linor Ishay, Regev Cohen, Alaa Atamna, Amy Spallone, Roy F Chemaly, Juan Carlos Ramos-Ramos, Michal Chowers, Evgeny Rogozin, Noga Carmi Oren, Şiran Keske, Orit Wolfovitz Barchad, Lior Nesher, null null
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab. Cancer medicine 13 (3) (2024)
Shimrit Ringelstein-Harlev, Mona Fanadka, Netanel A Horowitz, Noam P Bettman, Tami Katz
In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T-cell inhibitory properties, contributing to immunosuppression. European journal of haematology (2022)
Liat Shargian-Alon, Odelia Amit, Hanna Bernstine, Ronit Gurion, Anat Gafter-Gvili, Uri Rozovski, Oren Pasvolsky, Galit Perets, Netanel A Horowitz, Jabour Halloun, Chava Perry, Irit Avivi, Pia Raanani, Moshe Yeshurun, Ron Ram
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study. European journal of haematology (2022)
Neta Schiller Salton, Moran Szwarcwort, Inna Tzoran, Netanel A Horowitz, Tsila Zukerman, Nurit Horesh, Yael Shachor-Meyouhas, Khetam Hussein, Noa Lavi
Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis. American journal of hematology 96 (12) (2021)
Yael Morgenstern, Shlomzion Aumann, Neta Goldschmidt, Moshe E Gatt, Boaz Nachmias, Netanel A Horowitz
Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study. Cancer medicine (2021)
David Azoulay, Netanel A Horowitz
Brain-derived neurotrophic factor as a potential biomarker of chemotherapy-induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization. British journal of haematology 191 (1) (2020)
Yishai Ofran, Michal Hayun, Ronit Leiba, Tsila Zukerman, Netanel A Horowitz, Ron Hoffman, Shimrit Ringelstein, Noa Lavi, Avraham Frisch, Israel Henig, Moshe E E Gatt, Ilana Hellmann, Ariela Arad, Shlomo Bulvik, Ron Ram, Sharon Gino-Moor, Revital Saban, Ariella Tvito, Jacob M Rowe, Chezi Ganzel
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study. American journal of hematology 95 (1) (2019)
Shai Shimony, Netanel A Horowitz, Elena Ribakovsky, Uri Rozovski, Abraham Avigdor, Keren Zloto, Tamar Berger, Irit Avivi, Chava Perry, Uri Abadi, Pia Raanani, Anat Gafter-Gvili, Ronit Gurion
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study. Hematological oncology 37 (5) (2019)
Chava Perry, Sharon Ben Barouch, Neta Goldschmidt, Nadav Sarid, Yair Herishanu, Lev Shvidel, Osnat Bairey, Noa Lavi, Netanel A Horowitz, Avraham Avigdor, Eyal Lebel, Orit Sofer, Ron Ram, Irit Avivi
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study. American journal of hematology 94 (9) (2019)